Loading clinical trials...
Loading clinical trials...
Open Label Phase II Study Evaluating the Efficacy and Safety of the Combination of Tagraxofusp and Venetoclax in Treatment-naive Blastic Plasmacytoid Dendritic Cell Neoplasm Patients
Conditions
Interventions
Venetoclax
Tagraxofusp
Locations
34
France
AMIENS - CH Amiens Picardie Site Sud
Amiens, France
ANGERS - CHU - Maladies du sang
Angers, France
ARGENTEUIL - Centre hospitalier Victor Dupouy
Argenteuil, France
AVIGNON - Centre Hospitalier
Avignon, France
BESANCON - Hôpital Jean Minjoz - Hématologie
Besançon, France
CLAMART - Hôpital d'Instruction des Armées de Percy
Clamart, France
Start Date
December 1, 2025
Primary Completion Date
January 31, 2026
Completion Date
September 30, 2031
Last Updated
November 26, 2025
NCT06006403
NCT04013685
NCT03203369
Lead Sponsor
French Innovative Leukemia Organisation
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions